Joysoual, M. R. (2026) “Safety of Empagliflozin as Add-on Therapy in Patients with Uncontrolled Type 2 Diabetes Mellitus”, KYAMC Journal, 16(3), pp. 119–122. doi: 10.3329/kyamcj.v16i3.88022.